Evidence map›Paper›PMID 38229460›Full record

ReviewThe Journal of international medical research2024

Folic acid: friend or foe in cancer therapy.

Romany H Thabet, Raneem Eid Mustafa Alessa, Zahraa Khaldoon Khaleel Al-Smadi, Banah Saleh Gabr Alshatnawi, Batool Mahmoud Ibrahim Amayreh, Renad Bilal Ahmad Al-Dwaaghreh, Sereen Khalid Ahmad Salah

Open access · goldAbstract readReview
In one paragraph

Review in The Journal of international medical research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 1 pooled it
13.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 1 synthesis or guideline pooled it, 29 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Association of serum folate concentrations with the mortality of cancer: a prospective cohort study.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2025
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Romany H ThabetDepartment of Pharmacology, Faculty of Medicine, Assiut University, Assiut, Egypt.ORCID 0000-0001-9566-4034
Raneem Eid Mustafa AlessaDepartment of Basic Medical Sciences, Faculty of Medicine, Yarmouk University, Irbid, Jordan.
Zahraa Khaldoon Khaleel Al-SmadiDepartment of Basic Medical Sciences, Faculty of Medicine, Yarmouk University, Irbid, Jordan.
Banah Saleh Gabr AlshatnawiDepartment of Basic Medical Sciences, Faculty of Medicine, Yarmouk University, Irbid, Jordan.
Batool Mahmoud Ibrahim AmayrehDepartment of Basic Medical Sciences, Faculty of Medicine, Yarmouk University, Irbid, Jordan.
Renad Bilal Ahmad Al-DwaaghrehDepartment of Basic Medical Sciences, Faculty of Medicine, Yarmouk University, Irbid, Jordan.
Sereen Khalid Ahmad SalahIntern Doctor at Princess Basma Hospital, Ministry of Health, Irbid, Jordan.
Yarmouk University · JOAssiut University · EGMinistry of Health · JO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Folic acid plays a crucial role in diverse biological processes, notably cell maturation and proliferation. Here, we performed a literature review using articles listed in electronic databases, such as PubMed, Scopus, MEDLINE, and Google Scholar. In this review article, we describe contradictory data regarding the role of folic acid in cancer development and progression. While some studies have confirmed its beneficial effects in diminishing the risk of various cancers, others have reported a potential carcinogenic effect. The current narrative review elucidates these conflicting data by highlighting the possible molecular mechanisms explaining each point of view. Further multicenter molecular and genetic studies, in addition to human randomized clinical trials, are necessary to provide a more comprehensive understanding of the relationship between folic acid and cancer.

Indexed as

Folic AcidNeoplasmsDietary SupplementsHumansMulticenter Studies as TopicFolic AcidBreast cancercarcinogeniccolorectal cancerfolatefolic acidlung cancerprostate cancer

Identifiers

PMID38229460
PMCPMC10935767
OpenAlexW4390952115

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.